71 related articles for article (PubMed ID: 2347414)
1. Who gets a second primary cancer after gastric cancer surgery?
Janssen CW; Lie RT; Maartmann-Moe H; Matre R
Eur J Surg Oncol; 1990 Jun; 16(3):195-9. PubMed ID: 2347414
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of preoperative serum immunoglobulin and complement component concentrations in patients with gastric carcinoma.
Janssen CW; Tønder O; Matre R
Acta Chir Scand; 1985; 151(1):57-61. PubMed ID: 3984657
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of postoperative serum immunoglobulin and complement component concentrations following gastric resection for carcinoma.
Janssen CW; Tønder O; Matre R
Acta Chir Scand; 1985; 151(1):63-7. PubMed ID: 3984658
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of immunoglobulins and complement components in patients with recurrence after resection of gastric carcinoma.
Janssen CW; Tønder O; Matre R
Cancer Detect Prev; 1987; 10(3-4):303-9. PubMed ID: 3568028
[TBL] [Abstract][Full Text] [Related]
5. The postoperative recurrence and the occurrence of second primary carcinomas in patients with early gastric carcinoma.
Yamamoto M; Yamanaka T; Baba H; Kakeji Y; Maehara Y
J Surg Oncol; 2008 Mar; 97(3):231-5. PubMed ID: 18095298
[TBL] [Abstract][Full Text] [Related]
6. Preoperative prediction of extent and prognosis of gastric carcinoma by four serum proteins and erythrocyte sedimentation rate.
Janssen CW; Maartmann-Moe H; Lie RT
Eur J Surg Oncol; 1987 Aug; 13(4):285-95. PubMed ID: 3622781
[TBL] [Abstract][Full Text] [Related]
7. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
8. The influence of the host on the course of gastric carcinoma.
Janssen CW; Lie RT; Bassøe CF; Maartmann-Moe H; Matre R
Br J Cancer; 1992 Nov; 66(5):870-4. PubMed ID: 1419630
[TBL] [Abstract][Full Text] [Related]
9. Serum C1-esterase inhibitor, an essential and independent prognosticator of gastric carcinoma.
Janssen CW; Lie RT; Maartmann-Moe H; Matre R
Br J Cancer; 1989 Oct; 60(4):589-91. PubMed ID: 2803929
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features of patients who died with second primary cancer after curative resection for gastric cancer.
Maehara Y; Tomisaki S; Emi Y; Sakaguchi Y; Kusumoto T; Ichiyoshi Y; Sugimachi K
Anticancer Res; 1995; 15(3):1049-53. PubMed ID: 7645924
[TBL] [Abstract][Full Text] [Related]
11. Multiple primary colorectal and gastric carcinoma in Japan.
Tomoda H; Taketomi A; Baba H; Kohnoe S; Seo Y; Saito T
Oncol Rep; 1998; 5(1):147-9. PubMed ID: 9458311
[TBL] [Abstract][Full Text] [Related]
12. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection.
Nasu J; Doi T; Endo H; Nishina T; Hirasaki S; Hyodo I
Endoscopy; 2005 Oct; 37(10):990-3. PubMed ID: 16189772
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features of multiple primary gastric carcinoma.
Kodama M; Tur GE; Shiozawa N; Koyama K
J Surg Oncol; 1996 May; 62(1):57-61. PubMed ID: 8618403
[TBL] [Abstract][Full Text] [Related]
16. Multiple primary gastric and colorectal cancer in Japan.
Ikeda Y; Mori M; Kajiyama K; Haraguchi Y; Sugimachi K
Int Surg; 1995; 80(1):37-40. PubMed ID: 7657488
[TBL] [Abstract][Full Text] [Related]
17. Synchronous and metachronous primary malignancies in organs other than the stomach in patients with early gastric cancer.
Ikeguchi M; Ohfuji S; Oka A; Tsujitani S; Maeda M; Kaibara N
Hepatogastroenterology; 1995; 42(5):672-6. PubMed ID: 8751233
[TBL] [Abstract][Full Text] [Related]
18. Detection and prognosis of recurrent gastric cancer--is routine follow-up after gastrectomy worthwhile?
Böhner H; Zimmer T; Hopfenmüller W; Berger G; Buhr HJ
Hepatogastroenterology; 2000; 47(35):1489-94. PubMed ID: 11100384
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of gastric outlet obstruction on the oncologic and surgical outcomes of radical surgery for carcinoma of the distal stomach.
Park SH; Mok YJ; Kim JH; Park SS; Kim SJ; Kim CS
J Surg Oncol; 2009 Sep; 100(3):215-21. PubMed ID: 19235783
[TBL] [Abstract][Full Text] [Related]
20. [The surgical treatment of gastric carcinoma. Evolution in surgical technique and staging in a series of 194 patients].
Tersigni R; Alessandroni L; Baiano G; Mencacci R; Miceli M; Sadighi A; Sorgi G; Tremiterra S
Minerva Chir; 2004 Oct; 59(5):479-87. PubMed ID: 15494675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
